product Image
DiaPlexQ™ 5 types Corneal Dystrophy (CD) Genotyping Kit (Corneal Dystrophy)
Model Name
-
Series
Molecular Diagnostic (Human Gentrifyping)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125227
Product Name
DiaPlexQ™ 5 types Corneal Dystrophy (CD) Genotyping Kit (Corneal Dystrophy)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexQ™ 5 types Corneal Dystrophy (CD) Genotyping Kit

Real-Time PCR based assay system for the genotyping of the SNP of codon 124, 555(exon4) in TGFβ1 related to avellino corneal dystrophy

CE-IVD


The TGFβI gene is firstly appear at the 5q31 chromosome related corneal dystrophy on the corneal epithelium. Morbid cover of TGFβI is detected from the cornea, so we suppose the cause of disease related on 5q31 chromosome. There are Avellino Corneal Dystrophy(ACD), Reis-Buckler’s Corneal dystrophy(RBCD), lattice Corneal dystrophy(LCD), granular Corneal dystrophy(GCD type1), Thiel-Behnke Corneal Dystrophy(TBCD) which are related with chromosome 5q31 and TGFβI gene. The IC3D had classified the diseases as category1. Although there are some remedies like sublayer corneal transplantation and penetrating keratoplasty, there are many cases that the disease recur after the operation. In case of heterozygote people perform the laser surgery such as like LASEK or LASIK. There is possibility of lose eye sight caused by corneal opacity. The Coneal Dystrophy genetic diagnosis before LASEK, LASEK surgery is kind of essential clinical test.





Specification

Detection targetSNP of codon 124, 555 in TGFβI (R124H, R124L, R124C, R555Q, R555W)
RegistrationCE-IVD
Detection technologyReal-Time PCR
Specimen typeBlood, Buccal epithelial cell
Compatible instruments*ABI 7500 / 7500 Fast Real-Time PCR System (Applied Biosystems)
CFX96™ Real-Time PCR System (Bio-Rad)
PCR running time~ 3hr




Features

- HotStart PCR system : Ultra high specific and sensitive result

- UDG system : No carryover contamination

- Multiplex PCR : Multiple targets in a single reaction

- Reliable system : Automatic Internal control ( DiaPlex C™)

- Positive control included

- Easy-to-use master mix

- CE certification





Experimental


ColorGenotyping
RedWild-type
BlueMutant type (ACD, RBCD, LCD, TBCD, GCD)
GreenCD Hetero type
● Black

Non-Template Control






Citation&Papers

Ridgway AEA, Moller HU (1992)

Genetics of granular dystrophy. Ophthalmology 99:175

Rogers C, Cohen P, Lawless M (1993)

Phototherapeutic keratectomy for Reis-Bucklers‘corneal dystrophy. Aust N Z J Ophthalmol 21:247–25

Munier FL, Korvatska E, Djema¨ı A, Le Paslier D, Zografos L, Pescia G, Schorderet DF(1997)

Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 15:247–25

Garner A.

Histochemistry of corneal granular dystrophy. Br J Ophthalmol 1969;53:799 805.

Akiya S, Brown SI.

Granular dystrophy of the cornea: characteristic electron microscopic lesion. Arch Ophthalmol 1970;84:179–92.

Owens SL, Sugar J. Edward DP.

Superficial granular corneal dystrophy with amyloid deposit. Arch Ophthalmol 1992;110:175–6.

Holland EJ, Daya SM, Stone EM, et al.

Avellino corneal dystrophy: clinical manifestations and natural history. Ophthalmology 1992;99:1564–8.






Ordering information

TechnologyCat. No.ProductContents



Real-Time PCR
SQH29-K020 (20 reaction)

DiaPlexQ ™ 5 type Corneal Dystrophy(CD) Genotyping Kit
2X Multiplex Real-Time PCR Smart mix (CD)
Primer & Probe Mixture (CD)
Wild-type Control Template (CD)
Hetero-type Control Template (CD)
Mutant-type Control Template (CD)
Nuclease free Water
SQH29-K100 (100 reaction)




More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry